India and Norway fight antibiotic resistance through six new joint research projects

antibiotic
Methicillin-Resistant Staphylococcus aureus (MRSA) Bacteria. Photo: NIAID from Flickr.

In December 2016, the Research Council of Norway and Indian Council for Medical Research published a joint call for proposals. There were 28 applications submitted for the deadline in April. Six projects have now been granted.

Historical cooperation with India
The Indo-Norwegian research collaboration on antimicrobial resistance is historical. This is a global health challenge where knowledge and research needs are greater than any country can solve alone.

The announcement had a one-health perspective in line with the Norwegian government's strategy against antibiotic resistance and covered the full width of the field from monitoring, action, treatment, diagnostics and resistance development. The majority of applications were within the field of treatment and diagnostics. Prior to the bilateral announcement, RCN organized a "match making workshop" in New Delhi for Norwegian and Indian researchers.

Parallel application assessment
The scientific quality of the applications was assessed in parallel on the Norwegian and Indian sides. An international panel of experts assessed the applications for the Research Council and Indian experts assessed the applications for ICMR.

Applications that were recommended from both Norwegian and Indian sides were assessed in a joint resolution meeting between the Research Council and the ICMR. In addition to academic quality, emphasis was placed on relevance for the announcement, dissemination of thematic / portfolio and the added value of Indian-Norwegian cooperation.

The six projects which were set for funding have been revised on the basis of input from the Norwegian and Indian experts on the subject to ensure that the projects build capacity within ethical guidelines and contribute to the necessary knowledge development on antimicrobial resistance in a global perspective. The Health Ministry's Screening Committee in India approved the six projects on 27 October.

India member of JPIAMR
India has recently become a partner in the European Joint Initiative for Anti Microbial resistance. JPIAMR is a global platform that coordinates research on antimicrobial resistance in a one-health perspective. Priority areas in the strategic research agenda are followed by transnational calls, where the establishment of Indian-Norwegian cooperation may have an added value.

  

Project    number

  
  

Project    title

  
  

Institution    in Norway

  
  

Institution    in India

  

273588

Structure-based target   exploration for the discovery of new leads for antibiotics

University of   Bergen

CSIR-India Institute of   Chemical Technology Tarnaka, Hyderabad

273609

AMR-Diag: A Novel Diagnostic   Tool for Sequence Based Prediction of Antimicrobial Resistance

Inland Norway University of   Applied Sciences (INN University)

Department of Biophysics AIIMS   New Delhi

273646

Antimicrobial peptides   (bacteriocins) as alternative to conventional antibiotics

Norwegian University of Life   Sciences (NMBU)

LEPRA Society-Blue Peter Public   Health and Research Center, Hyderabad, Telangana

273833

Born in the twilight of   antibiotics: Implications of antibiotic use to the preterm infant respiratory   mcirobiome and resistome development

University of Oslo

Lady Hardinge Medical College,   New Delhi

273319

Drug targeting for improved   treatment of multi drug resistant tuberculosis.

University of Oslo

CSIR- Central Drug Research   Institute, Lucknow

273332

Detection and Inhibition of   clinically relevant carbapenemases (DICARBA)

UiT the Arctic university of   Norway

Indian Institute of Technology   (IIT) Roorkee, Uttarakhand